The Latest News

AACR will be holding the Second Shanghai Conference during November 12-15

AACR will be holding the Second Shanghai Conference entitled "New Horizons in Cancer Research" during November 12-15 in Shanghai, China. Our Board of Directors, Dr. Wei Zhang, serves on the Regional Advisory Committee and has been invited to give two presentations on cancer genomics at the conference.

The first Impact Factor of CJC is 2.155.

We are pleased to announce that the first Impact Factor of CJC is 2.155 !

Last year, the Chinese Journal of Cancer (CJC) was accepted in the Science Citation Index Expanded (SCI-E) by Thomson Reuters.

It has then been granted an Impact Factor of 2.155 for the of 2014, reflecting the citations during the year 2014 of articles published in 2012 and 2013.

Lung cancer and its prevalence in China: an Editor Q+A

Cases of lung cancer in China are rising, but why is this? Editors of a new series on lung cancer, Li Yan and Wei Zhang, explain why occurrence of lung cancer is increasing in China and the work that is being done to prevent this.

http://blogs.biomedcentral.com/on-medicine/2015/08/05/lung-cancer-preval...

Long time USCACA supporter and advisor, Dr. George Wilding, appointed vice provost for clinical and interdisciplinary research at MD Anderson Cancer Center

Long time USCACA supporter and advisor, Dr. George Wilding, appointed vice provost for clinical and interdisciplinary research at MD Anderson Cancer Center
----
HOUSTON ― The University of Texas MD Anderson Cancer Center is pleased to announce the appointment of George Wilding, M.D., as vice provost for clinical and interdisciplinary research. Dr. Wilding is a prominent prostate cancer physician-scientist who directed the University of Wisconsin’s Carbone Cancer Center (UWCCC) for 12 years. His appointment at MD Anderson begins Sept. 1.

The 7th Annual Meeting of The US Chinese Anti-Cancer Association (USCACA) at AACR 2015 in Philadelphia

Philadelphia, PA — (May 6, 2015) On April 19, 2015, more than 100 cancer researchers worldwide from academia, industry, and government agencies attended the 7th Annual USCACA Meeting at AACR 2015, organized by a committee consisting of sixteen Executive Members of the USCACA.

AFCR-funded Scientists Discover New Drug Combination to Overcome Chemotherapy Resistance in Ovarian Cancer

AFCR-funded Scientists Discover New Drug Combination to Overcome Chemotherapy Resistance in Ovarian Cancer

Shanghai-Based Biotech, Backed by Preeminent VCs, Seeks Chief Medical Officer

Shanghai-Based Biotech, Backed by Preeminent VCs, Seeks Chief Medical Officer

Occam Global is a strategic executive search firm with substantial experience serving entrepreneurial companies in the Healthcare and Technology sectors.

USCACA Board of Director Member in the News

Jan. 21st, 2015, Paris

2014 Chinese Clinical Oncology Advances Awards Announced

2014 Chinese Clinical Oncology Advances Awards Announced
From China Medical Tribune

Pages